<p>The present invention relates to the preparation of a <2 adrenergic agonist in crystalline salt form. In particular the invention relates to preparation of a crystalline salt of compound (I): in particular a crystalline monohydrochloride salt. The invention also relates to a new crystalline form (polymorph) of the monohydrochloride salt of compound (Ia) and a process for preparing it.</p>
申请公布号
WO2005095328(A1)
申请公布日期
2005.10.13
申请号
WO2005GB01241
申请日期
2005.03.30
申请人
GLAXO GROUP LIMITED;CAINE, DARREN, MICHAEL;PATERNOSTER, IAN, LEONARD;SHAPLAND, PETER, DAVID, PENBERTHY
